460 participants
Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-10-21
- Start Date:
- 2024-11-01
- Completion:
- 2027-11-01
Conditions
- Mycosis Fungoides/Sezary Syndrome
- Cutaneous T Cell Lymphoma
Interventions
- OTHER
No Results Yet